Advertisement

Treatment of Graves’ Ophthalmopathy by Retrobulbar Corticosteroids Associated With Orbital Cobalt Radiotherapy

  • Claudio Marcocci
  • Luigi Bartalena
  • Massimo Panicucci
  • Giuliano Cavallacci
  • Claudio Marconcini
  • Antonio Lepri
  • Michele Laddaga
  • Francesco Cartei
  • Aldo Pinchera

Abstract

Combined therapy with systemic corticosteroids and orbital cobalt radiotherapy (RT) has proven an effective method for treatment of severe Graves’ ophthalmopathy (1). The use of large doses of systemic corticosteroids is potentially risky. In more than 100 patients treated so far at our Institution with systemic corticosteroids either alone or in combination with radiotherapy, relevant side effects have been observed in 4 cases: one patient had an increase of intraocular tension, one showed depressive psychosis, one developed diabetic syndrome requiring insulin, and one had infective encephalitis within the first month of treatment (2). This prompted us to assess the therapeutic effectiveness of retrobulbar long-acting corticosteroids (RBC) in substitution for systemic corticosteroids in the combined therapy in a group of 44 consecutive patients with active Graves’ ophthalmopathy.

Keywords

Optic Neuropathy Systemic Corticosteroid Extraocular Muscle Active Grave Methylprednisolone Acetate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    L. Bartalena, C. Marcocci, L. Chiovato, M. Laddaga, G. Lepri, D. Andreani, G. Cavallacci, L. Baschieri, and A. Pinchera, Orbital cobalt irradiation combined with systemic corticosteroids for Graves’ ophthalmopathy: comparison with systemic corticosteroids alone, J. Clin. Endocrinol. Metab. 56:1139 (1983).PubMedCrossRefGoogle Scholar
  2. 2.
    A. Pinchera, L. Bartalena, L. Chiovato, and C. Marcocci, Radiotherapy of Graves’ ophthalmopathy, in.: “The Eye and Orbit in Thyroid Disease”, C.A. Gorman, R.R. Waller, and J.A. Dyer, eds., Raves Press, New York, p. 301, (1984).Google Scholar
  3. 3.
    S.S. Donaldson, M.A. Bagshaw, and J.P. Kriss, Supervoltage orbital radiotherapy for Graves’ ophthalmopathy, J. Clin. Endocrinol. Metab. 37:276 (1973).PubMedCrossRefGoogle Scholar
  4. 4.
    I.D. Thomas and J.K. Hart, Retrobulbar repository corticosteroid therapy in thyropid ophthalmopathy, Med. J. Austl. 2:484 (1974).Google Scholar
  5. 5.
    M.I. Garber, Methylprednisolone in the treatment of exophthalmos, Lancet 1:958 (1966).PubMedCrossRefGoogle Scholar
  6. 6.
    D.H. Jacobson and C.A. Gorman, Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and treatment. Endocr. Rev. 5:200 (1984)PubMedCrossRefGoogle Scholar
  7. 7.
    C. Marcocci, L. Bartalena, M. Panicucci, C. Marconcini, F. Cartei, G. Cavallacci, M. Laddaga, G. Campobasso, L. Baschieri, and A. Pinchera, Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves’ ophthalmopathy: a comparative study, Clin. Endocrinol.(Oxf) in pressGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Claudio Marcocci
    • 1
  • Luigi Bartalena
    • 1
  • Massimo Panicucci
    • 1
  • Giuliano Cavallacci
    • 2
  • Claudio Marconcini
    • 2
  • Antonio Lepri
    • 2
  • Michele Laddaga
    • 3
  • Francesco Cartei
    • 3
  • Aldo Pinchera
    • 1
  1. 1.Cattedra di Endocrinologia e Medicina CostituzionaleUniversita di PisaTirrenia (Pisa)Italy
  2. 2.Clinica OculisticaUniversita di PisaTirrenia (Pisa)Italy
  3. 3.Cattedra di RadioterapiaUniversita di PisaTirrenia (Pisa)Italy

Personalised recommendations